Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.

Xu, Fei-Fei; Cao, Lu; Xu, Cheng; Cai, Gang; Wang, Shu-Bei; Qi, Wei-Xiang; Chen, Jia-Yi

Xu, Fei-Fei; Cao, Lu; Xu, Cheng; Cai, Gang; Wang, Shu-Bei; Qi, Wei-Xiang; Chen, Jia-Yi.

Afiliação

Xu FF; Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Cao L; Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Xu C; Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Cai G; Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Wang SB; Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Qi WX; Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Chen JY; Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Front Oncol ; 12: 789198, 2022.

Article em En | MEDLINE | ID: mdl-35280719

Palavras-chave

T1-2N1; breast cancer; postmastectomy radiotherapy; risk factors; survival prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google